Geke A P Hospers Selected Research

Systemic Vasculitis

1/2018

Systemic vasculitis developed after immune checkpoint inhibition: comment on the article by Cappelli et al.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Geke A P Hospers Research Topics

Disease

56	Melanoma (Melanoma, Malignant) 02/2024 - 01/2003
46	Neoplasms (Cancer) 12/2023 - 01/2002
22	Breast Neoplasms (Breast Cancer) 02/2024 - 11/2004
17	Rectal Neoplasms (Rectal Cancer) 04/2024 - 03/2004
16	Neoplasm Metastasis (Metastasis) 01/2024 - 07/2011
10	Esophageal Neoplasms (Esophageal Cancer) 07/2021 - 06/2013
9	Brain Neoplasms (Brain Tumor) 05/2023 - 01/2018
5	Adenocarcinoma 01/2021 - 06/2013
5	Stomach Neoplasms (Stomach Cancer) 09/2018 - 06/2010
2	Carcinoma (Carcinomatosis) 04/2017 - 01/2005
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2015 - 06/2013
2	Colorectal Neoplasms (Colorectal Cancer) 06/2013 - 11/2011
2	Colonic Neoplasms (Colon Cancer) 06/2013 - 05/2006
2	Vascular Diseases (Vascular Disease) 01/2007 - 02/2006
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2005 - 09/2004
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 02/2024
1	Body Weight (Weight, Body) 12/2022
1	Death (Near-Death Experience) 10/2022
1	Inflammation (Inflammations) 09/2022
1	Lymphatic Metastasis 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022
1	Hepatitis 04/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Immune System Diseases (Immune Disorders) 01/2021

Drug/Important Bio-Agent (IBA)

25	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2016
13	IpilimumabIBA 01/2023 - 11/2013
12	Estrogen ReceptorsIBA 11/2022 - 02/2012
10	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2024 - 01/2021
10	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2010
9	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024 - 05/2014
8	16-fluoroestradiolIBA 01/2023 - 01/2018
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2011 - 01/2003
7	NivolumabIBA 01/2023 - 01/2022
6	VemurafenibIBA 12/2023 - 05/2013
6	Estradiol (Delestrogen)FDA LinkGeneric 11/2022 - 10/2015
5	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2005
5	Capecitabine (Xeloda)FDA Link 01/2020 - 01/2005
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2018 - 01/2005
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2024 - 11/2018
3	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 12/2017
3	human ERBB2 proteinIBA 10/2020 - 12/2017
3	Paclitaxel (Taxol)FDA LinkGeneric 09/2018 - 08/2014
3	Carboplatin (JM8)FDA LinkGeneric 09/2018 - 08/2014
2	Trinitrotoluene (TNT)IBA 10/2023 - 01/2022
2	CytokinesIBA 09/2022 - 07/2016
2	pembrolizumabIBA 09/2022 - 07/2019
2	Trastuzumab (Herceptin)FDA Link 10/2020 - 01/2020
2	Formaldehyde (Formol)FDA Link 01/2020 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 11/2018 - 01/2011
2	ParaffinIBA 01/2018 - 01/2015
2	GenisteinIBA 11/2017 - 04/2017
2	2- fluoro- 6- (6- hydroxynaphthalen- 2- yl)pyridin- 3- olIBA 11/2017 - 04/2017
2	Estrogens (Estrogen)FDA Link 04/2017 - 11/2016
2	Phosphotransferases (Kinase)IBA 01/2017 - 01/2011
2	Proto-Oncogene Proteins B-rafIBA 01/2017 - 04/2014
2	LigandsIBA 01/2015 - 11/2004
2	Bevacizumab (Avastin)FDA Link 01/2015 - 07/2011
2	Fluorouracil (Carac)FDA LinkGeneric 05/2006 - 01/2005
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2005 - 01/2003
1	cobimetinibIBA 12/2023
1	Interferon-gamma (Interferon, gamma)IBA 12/2023
1	Polysaccharides (Glycans)IBA 02/2023
1	Blood Proteins (Serum Proteins)IBA 02/2023
1	PRIMMIBA 01/2023
1	CTLA-4 AntigenIBA 12/2022
1	A-factor (Streptomyces)IBA 09/2022
1	Interleukin-6 (Interleukin 6)IBA 09/2022
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 12/2021
1	Interleukin-2 (IL2)IBA 12/2021
1	antineoplaston A10 (A 10)IBA 09/2021
1	Programmed Cell Death 1 ReceptorIBA 04/2021
1	bicalutamide (Casodex)FDA LinkGeneric 01/2021
1	AntibodiesIBA 01/2021
1	Dihydrotestosterone (Androstanolone)IBA 01/2021
1	AZD 6244IBA 12/2020
1	BMS-986192IBA 12/2020
1	Lactate DehydrogenasesIBA 11/2020
1	pertuzumabIBA 10/2020
1	GRB7 Adaptor ProteinIBA 10/2020
1	ErbB Receptors (EGF Receptor)IBA 10/2020
1	Letrozole (Femara)FDA LinkGeneric 01/2020
1	FluoridesIBA 01/2020
1	SodiumIBA 01/2020

Therapy/Procedure

48	Therapeutics 01/2024 - 08/2004
18	Chemoradiotherapy 04/2024 - 06/2013
18	Radiotherapy 04/2024 - 03/2004
17	Neoadjuvant Therapy 04/2024 - 11/2013
11	Drug Therapy (Chemotherapy) 01/2023 - 01/2003
3	Adjuvant Chemotherapy 01/2021 - 06/2013
2	Adjuvant Chemoradiotherapy 09/2018 - 01/2005
2	Esophagectomy 07/2016 - 02/2014
1	Mediterranean Diet 01/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2022
1	Aftercare (After-Treatment) 12/2022
1	Combined Modality Therapy 04/2022
1	Duration of Therapy 01/2022
1	Lymph Node Excision (Lymph Node Dissection) 01/2022
1	Re-Irradiation 09/2021
1	Brachytherapy 01/2021
1	Immunotherapy 05/2020